Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06030986

Prediction of Outcome in Out-of-Hospital Cardiac Arrest

In the course of prehospital respiratory and circulatory arrest, approximately 1000 persons are resuscitated by cardiopulmonary resuscitation in Upper Austria every year. Despite constant further development of methods, equipment and continuous training of the rescue and emergency medical teams working on site, the majority of patients who have to be resuscitated prehospital still die. However, even patients whose circulatory function can be restored during prehospital resuscitation (Return of Spontaneous Circulation, ROSC) require intensive medical care for days to weeks and often find it very difficult to return to a normal, independent life.

The success of resuscitation measures depends on the quality of the resuscitation performed as well as on patient-specific factors. Evaluation scales such as the Cerebral Performance Category score (CPC) allow a posteriori assessment of resuscitation success. Nowadays, it is very difficult to estimate the outcome of resuscitation a priori. In many cases, it is not at all clear at the beginning of the treatment pathway whether the individual patient is expected to have an unfavorable prognosis in the context of respiratory arrest or whether a restitutio ad integrum is possible.

Thus, the decision to continue or discontinue resuscitation can only be made on the basis of an individual physician's assessment. In addition to the primary concern of stopping resuscitation too early, there is also the risk that medical resources are used beyond the normal level after resuscitation without expecting a successful outcome. Estimating and categorizing the subsequent outcome is difficult and emotionally stressful for the treating team in the acute situation. Some factors that influence outcome are now known: As cerebral hypoperfusion increases, the probability of survival decreases sharply with each passing minute. In this context, potentially reversible causes have been identified in different works, allowing causal therapy to improve neurological outcome. In addition to the most important therapy bridging hypoperfusion, chest compression, with the aim of ensuring minimal perfusion of the brain, immediate defibrillation should be mentioned in particular, which now allows medical laypersons to use defibrillators as part of the Public Access Defibrillation Network.

Despite all efforts, however, it is not yet possible to make reliable statements about the probable outcome of persons with respiratory and circulatory arrest with a high degree of certainty in a large number of cases at an early stage.

Artificial intelligence refers to the ability of machines to perform cognitive tasks, such as recognizing objects in images and classifying them. For a long time, many processes were too complex to explore through sufficient computing power, storage capacity, and understanding. More recently, however, technological advances have brought machine learning (ML) and the constructs behind it, including those based on so-called neural networks (known since about 1950), back to the fore. Not only the development of theoretical models, but after extensive testing also devices applicable in daily routine operation are available.

Modern machine learning methods are enabling a variety of new approaches to assessing operations, including modeling complex systems and finding relationships between models.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 18 years or older AND
  • between 2015-01-01 and 2023-10-31 AND
  • have been treated by emergency medical teams of the Austrian Red Cross, District Branch of Upper Austria AND
  • have suffered out-of-hospital cardiac arrest AND
  • have been treated by emergency physicians while out of hospital AND
  • have been transported to the Kepler University Hospital, Linz, Austria

Exclusion criteria

  • none

Treatment and study plan

ILCOR Utstein OHCA Core Outcome

Diagnostic Test

ILCOR Utstein OHCA Core Outcome

Primary outcomes

  1. AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome

    Time frame: 2015-01-01 - 2023-10-31

    AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome

  2. AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome

    Time frame: 2015-01-01 - 2023-10-31

    AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome

  3. F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome

    Time frame: 2015-01-01 - 2023-10-31

    F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome

  4. Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome

    Time frame: 2015-01-01 to 2023-10-31

    Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome

Secondary outcomes

  1. AUC-ROC for Prediction of Diagnosis at Hospital Discharge

    Time frame: 2015-01-01 - 2023-10-31

    AUC-ROC for Prediction of Diagnosis at Hospital Discharge

  2. AUC-PRC for Prediction of Diagnosis at Hospital Discharge

    Time frame: 2015-01-01 - 2023-10-31

    AUC-PRC for Prediction of Diagnosis at Hospital Discharge

  3. F1-Score for Prediction of Diagnosis at Hospital Discharge

    Time frame: 2015-01-01 - 2023-10-31

    F1-Score for Prediction of Diagnosis at Hospital Discharge

  4. Confusion Matrix for Prediction of Diagnosis at Hospital Discharge

    Time frame: 2015-01-01 - 2023-10-31

    Confusion Matrix for Prediction of Diagnosis at Hospital Discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Jens Meier, MD

CONTACT

[email protected]

+435768083 ext. 2158

Thomas Tschoellitsch, MD

CONTACT

[email protected]

+435768083 ext. 78132

Sponsors and collaborators

Lead sponsor

Kepler University Hospital

Other

Registry information

Acronym: PREDOHCA

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 11, 2023
Registry last updated
Jul 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.